World's Best Scientists 2026 revealed!

D-Index & Metrics

Discipline name D-Index World Ranking Current World Ranking National Ranking Current National Ranking Publications Citations
Medicine 80 17149 16118 8593 7941 250 22564

Jack W. Singer publications per year

The chart shows the history of publications by Jack W. Singer between 1973 and 2025, highlighting the no. of papers published in each year and offering an overview of the publication velocity of this scholar. Jack W. Singer published across 53 years, from 1973 to 2025, averaging 5.3 papers a year. Output peaked at 20 publications in 2023. 5 of the 280 publications appeared in the last two years.

No. of publications
5 10 15 20
Bar chart. Horizontal axis: year, 1973 to 2025. Vertical axis: number of publications, 0 to 20. Peak 20 publications in 2023. 1973: 1 publication 1974: 0 publications 1975: 0 publications 1976: 4 publications 1977: 3 publications 1978: 5 publications 1979: 10 publications 1980: 10 publications 1981: 4 publications 1982: 1 publication 1983: 5 publications 1984: 7 publications 1985: 6 publications 1986: 6 publications 1987: 9 publications 1988: 7 publications 1989: 10 publications 1990: 12 publications 1991: 5 publications 1992: 7 publications 1993: 12 publications 1994: 7 publications 1995: 3 publications 1996: 4 publications 1997: 2 publications 1998: 0 publications 1999: 1 publication 2000: 3 publications 2001: 3 publications 2002: 2 publications 2003: 5 publications 2004: 4 publications 2005: 9 publications 2006: 12 publications 2007: 9 publications 2008: 4 publications 2009: 7 publications 2010: 6 publications 2011: 7 publications 2012: 3 publications 2013: 3 publications 2014: 4 publications 2015: 2 publications 2016: 14 publications 2017: 3 publications 2018: 8 publications 2019: 2 publications 2020: 2 publications 2021: 0 publications 2022: 2 publications 2023: 20 publications 2024: 0 publications 2025: 5 publications
1973 2025

280 publications in total across all disciplines

View publications per year as a table
Jack W. Singer: publications per year, 1973 to 2025
Year Publications
1973 1
1974 0
1975 0
1976 4
1977 3
1978 5
1979 10
1980 10
1981 4
1982 1
1983 5
1984 7
1985 6
1986 6
1987 9
1988 7
1989 10
1990 12
1991 5
1992 7
1993 12
1994 7
1995 3
1996 4
1997 2
1998 0
1999 1
2000 3
2001 3
2002 2
2003 5
2004 4
2005 9
2006 12
2007 9
2008 4
2009 7
2010 6
2011 7
2012 3
2013 3
2014 4
2015 2
2016 14
2017 3
2018 8
2019 2
2020 2
2021 0
2022 2
2023 20
2024 0
2025 5
Total 280
Download as CSV

Jack W. Singer publication distribution in Medicine in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Medicine in 2026. The highlighted bar marks where Jack W. Singer sits on this spectrum.

No. of scientists
200 400 600 800
Bar chart with 86 bars. Horizontal axis: publications, 101–120 to 1,796+. Vertical axis: number of scientists, 0 to 922. Most scientists, 922, have 341–360 publications. The last bar groups every scientist with 1,796 publications or more. The highlighted bar, 241–260 publications, is where this scientist sits. 101–120 publications: 5 scientists 121–140 publications: 26 scientists 141–160 publications: 73 scientists 161–180 publications: 155 scientists 181–200 publications: 230 scientists 201–220 publications: 363 scientists 221–240 publications: 487 scientists 241–260 publications: 545 scientists 261–280 publications: 722 scientists 281–300 publications: 768 scientists 301–320 publications: 834 scientists 321–340 publications: 895 scientists 341–360 publications: 922 scientists 361–380 publications: 838 scientists 381–400 publications: 861 scientists 401–420 publications: 918 scientists 421–440 publications: 806 scientists 441–460 publications: 771 scientists 461–480 publications: 751 scientists 481–500 publications: 713 scientists 501–520 publications: 617 scientists 521–540 publications: 610 scientists 541–560 publications: 537 scientists 561–580 publications: 504 scientists 581–600 publications: 509 scientists 601–620 publications: 396 scientists 621–640 publications: 386 scientists 641–660 publications: 371 scientists 661–680 publications: 340 scientists 681–700 publications: 336 scientists 701–720 publications: 307 scientists 721–740 publications: 259 scientists 741–760 publications: 230 scientists 761–780 publications: 228 scientists 781–800 publications: 217 scientists 801–820 publications: 204 scientists 821–840 publications: 186 scientists 841–860 publications: 177 scientists 861–880 publications: 155 scientists 881–900 publications: 139 scientists 901–920 publications: 145 scientists 921–940 publications: 116 scientists 941–960 publications: 133 scientists 961–980 publications: 91 scientists 981–1,000 publications: 96 scientists 1,001–1,020 publications: 77 scientists 1,021–1,040 publications: 70 scientists 1,041–1,060 publications: 63 scientists 1,061–1,080 publications: 77 scientists 1,081–1,100 publications: 49 scientists 1,101–1,120 publications: 54 scientists 1,121–1,140 publications: 49 scientists 1,141–1,160 publications: 51 scientists 1,161–1,180 publications: 35 scientists 1,181–1,200 publications: 39 scientists 1,201–1,220 publications: 26 scientists 1,221–1,240 publications: 37 scientists 1,241–1,260 publications: 36 scientists 1,261–1,280 publications: 27 scientists 1,281–1,300 publications: 32 scientists 1,301–1,320 publications: 28 scientists 1,321–1,340 publications: 17 scientists 1,341–1,360 publications: 30 scientists 1,361–1,380 publications: 28 scientists 1,381–1,400 publications: 17 scientists 1,401–1,420 publications: 21 scientists 1,421–1,440 publications: 15 scientists 1,441–1,460 publications: 12 scientists 1,461–1,480 publications: 12 scientists 1,481–1,500 publications: 18 scientists 1,501–1,520 publications: 14 scientists 1,521–1,540 publications: 17 scientists 1,541–1,560 publications: 15 scientists 1,561–1,580 publications: 6 scientists 1,581–1,600 publications: 2 scientists 1,601–1,620 publications: 12 scientists 1,621–1,640 publications: 11 scientists 1,641–1,660 publications: 8 scientists 1,661–1,680 publications: 5 scientists 1,681–1,700 publications: 5 scientists 1,701–1,720 publications: 10 scientists 1,721–1,740 publications: 12 scientists 1,741–1,760 publications: 14 scientists 1,761–1,780 publications: 6 scientists 1,781–1,795 publications: 5 scientists 1,796+ publications: 100 scientists
101–120 publications 1,796+

This scientist: 250 publications — 8th percentile

8% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,796 publications or more.

View publications distribution as a table
Number of Medicine scientists by publication count, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
Publications Scientists This scientist
101–120 5
121–140 26
141–160 73
161–180 155
181–200 230
201–220 363
221–240 487
241–260 545 250
261–280 722
281–300 768
301–320 834
321–340 895
341–360 922
361–380 838
381–400 861
401–420 918
421–440 806
441–460 771
461–480 751
481–500 713
501–520 617
521–540 610
541–560 537
561–580 504
581–600 509
601–620 396
621–640 386
641–660 371
661–680 340
681–700 336
701–720 307
721–740 259
741–760 230
761–780 228
781–800 217
801–820 204
821–840 186
841–860 177
861–880 155
881–900 139
901–920 145
921–940 116
941–960 133
961–980 91
981–1,000 96
1,001–1,020 77
1,021–1,040 70
1,041–1,060 63
1,061–1,080 77
1,081–1,100 49
1,101–1,120 54
1,121–1,140 49
1,141–1,160 51
1,161–1,180 35
1,181–1,200 39
1,201–1,220 26
1,221–1,240 37
1,241–1,260 36
1,261–1,280 27
1,281–1,300 32
1,301–1,320 28
1,321–1,340 17
1,341–1,360 30
1,361–1,380 28
1,381–1,400 17
1,401–1,420 21
1,421–1,440 15
1,441–1,460 12
1,461–1,480 12
1,481–1,500 18
1,501–1,520 14
1,521–1,540 17
1,541–1,560 15
1,561–1,580 6
1,581–1,600 2
1,601–1,620 12
1,621–1,640 11
1,641–1,660 8
1,661–1,680 5
1,681–1,700 5
1,701–1,720 10
1,721–1,740 12
1,741–1,760 14
1,761–1,780 6
1,781–1,795 5
1,796+ 100
Download as CSV

Jack W. Singer D-index placement in Medicine in 2026

The chart shows the D-index (discipline H-index) distribution of Medicine scientists ranked by Research.com in 2026. The highlighted bar marks where Jack W. Singer sits on this spectrum.

No. of scientists
250 500 750 1,000
Bar chart with 75 bars. Horizontal axis: D-Index, 70–71 to 217+. Vertical axis: number of scientists, 0 to 1,027. Most scientists, 1,027, have 82–83 D-Index. The last bar groups every scientist with 217 D-Index or more. The highlighted bar, 80–81 D-Index, is where this scientist sits. 70–71 D-Index: 226 scientists 72–73 D-Index: 391 scientists 74–75 D-Index: 574 scientists 76–77 D-Index: 730 scientists 78–79 D-Index: 891 scientists 80–81 D-Index: 972 scientists 82–83 D-Index: 1,027 scientists 84–85 D-Index: 1,003 scientists 86–87 D-Index: 960 scientists 88–89 D-Index: 970 scientists 90–91 D-Index: 922 scientists 92–93 D-Index: 839 scientists 94–95 D-Index: 808 scientists 96–97 D-Index: 779 scientists 98–99 D-Index: 668 scientists 100–101 D-Index: 611 scientists 102–103 D-Index: 630 scientists 104–105 D-Index: 513 scientists 106–107 D-Index: 541 scientists 108–109 D-Index: 445 scientists 110–111 D-Index: 429 scientists 112–113 D-Index: 399 scientists 114–115 D-Index: 393 scientists 116–117 D-Index: 318 scientists 118–119 D-Index: 302 scientists 120–121 D-Index: 287 scientists 122–123 D-Index: 255 scientists 124–125 D-Index: 256 scientists 126–127 D-Index: 252 scientists 128–129 D-Index: 230 scientists 130–131 D-Index: 179 scientists 132–133 D-Index: 168 scientists 134–135 D-Index: 163 scientists 136–137 D-Index: 159 scientists 138–139 D-Index: 134 scientists 140–141 D-Index: 134 scientists 142–143 D-Index: 118 scientists 144–145 D-Index: 109 scientists 146–147 D-Index: 106 scientists 148–149 D-Index: 74 scientists 150–151 D-Index: 79 scientists 152–153 D-Index: 80 scientists 154–155 D-Index: 87 scientists 156–157 D-Index: 57 scientists 158–159 D-Index: 74 scientists 160–161 D-Index: 69 scientists 162–163 D-Index: 60 scientists 164–165 D-Index: 53 scientists 166–167 D-Index: 39 scientists 168–169 D-Index: 42 scientists 170–171 D-Index: 32 scientists 172–173 D-Index: 39 scientists 174–175 D-Index: 40 scientists 176–177 D-Index: 28 scientists 178–179 D-Index: 19 scientists 180–181 D-Index: 23 scientists 182–183 D-Index: 31 scientists 184–185 D-Index: 18 scientists 186–187 D-Index: 20 scientists 188–189 D-Index: 22 scientists 190–191 D-Index: 13 scientists 192–193 D-Index: 21 scientists 194–195 D-Index: 12 scientists 196–197 D-Index: 12 scientists 198–199 D-Index: 14 scientists 200–201 D-Index: 15 scientists 202–203 D-Index: 13 scientists 204–205 D-Index: 10 scientists 206–207 D-Index: 8 scientists 208–209 D-Index: 4 scientists 210–211 D-Index: 12 scientists 212–213 D-Index: 11 scientists 214–215 D-Index: 10 scientists 216 D-Index: 4 scientists 217+ D-Index: 98 scientists
70–71 D-Index 217+

This scientist: 80 D-Index — 16th percentile

16% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 217 D-Index or more.

View D-Index distribution as a table
Number of Medicine scientists by D-index, Research.com 2026 ranking edition. Based on 20,134 ranked scientists.
D-Index Scientists This scientist
70–71 226
72–73 391
74–75 574
76–77 730
78–79 891
80–81 972 80
82–83 1,027
84–85 1,003
86–87 960
88–89 970
90–91 922
92–93 839
94–95 808
96–97 779
98–99 668
100–101 611
102–103 630
104–105 513
106–107 541
108–109 445
110–111 429
112–113 399
114–115 393
116–117 318
118–119 302
120–121 287
122–123 255
124–125 256
126–127 252
128–129 230
130–131 179
132–133 168
134–135 163
136–137 159
138–139 134
140–141 134
142–143 118
144–145 109
146–147 106
148–149 74
150–151 79
152–153 80
154–155 87
156–157 57
158–159 74
160–161 69
162–163 60
164–165 53
166–167 39
168–169 42
170–171 32
172–173 39
174–175 40
176–177 28
178–179 19
180–181 23
182–183 31
184–185 18
186–187 20
188–189 22
190–191 13
192–193 21
194–195 12
196–197 12
198–199 14
200–201 15
202–203 13
204–205 10
206–207 8
208–209 4
210–211 12
212–213 11
214–215 10
216 4
217+ 98
Download as CSV

Overview

What is he best known for?

The fields of study he is best known for:

  • Internal medicine
  • Cancer
  • Gene

Jack W. Singer spends much of his time researching Internal medicine, Surgery, Immunology, Bone marrow and Gastroenterology. His Internal medicine research incorporates themes from Endocrinology and Oncology. His work in Immunology covers topics such as Stem cell which are related to areas like Molecular biology and Clone.

His Bone marrow study integrates concerns from other disciplines, such as Recombinant DNA, Microgram, Complication, Granulocyte macrophage colony-stimulating factor and Acute lymphocytic leukemia. His research in Gastroenterology intersects with topics in Methotrexate, Cyclophosphamide, Chemotherapy, Transplantation and Immunotherapy. His biological study spans a wide range of topics, including Clinical trial and Absolute neutrophil count.

His most cited work include:

  • Cisplatin-based adjuvant chemotherapy in patients with completely resected non-small-cell lung cancer. (1755 citations)
  • One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation. (789 citations)
  • Mechanisms of action of arsenic trioxide. (778 citations)

What are the main themes of his work throughout his whole career to date?

The scientist’s investigation covers issues in Internal medicine, Immunology, Surgery, Bone marrow and Haematopoiesis. The Internal medicine study combines topics in areas such as Gastroenterology and Oncology. The concepts of his Immunology study are interwoven with issues in Progenitor cell, Stem cell and Molecular biology.

His work on Transplantation, Chemotherapy and Regimen as part of general Surgery study is frequently linked to Placebo, bridging the gap between disciplines. His Bone marrow research includes elements of Acute lymphocytic leukemia and Granulocyte macrophage colony-stimulating factor. His work carried out in the field of Haematopoiesis brings together such families of science as Cell, Peripheral blood mononuclear cell, Philadelphia chromosome and Pathology.

He most often published in these fields:

  • Internal medicine (34.16%)
  • Immunology (38.27%)
  • Surgery (23.46%)

What were the highlights of his more recent work (between 2009-2020)?

  • Internal medicine (34.16%)
  • Pacritinib (7.00%)
  • Pharmacology (11.52%)

In recent papers he was focusing on the following fields of study:

His main research concerns Internal medicine, Pacritinib, Pharmacology, Surgery and Pixantrone. His work deals with themes such as Gastroenterology and Oncology, which intersect with Internal medicine. In his study, CHOP, Ejection fraction, Vincristine, Mantle cell lymphoma and Cyclophosphamide is strongly linked to Diffuse large B-cell lymphoma, which falls under the umbrella field of Gastroenterology.

His study in Pacritinib is interdisciplinary in nature, drawing from both Cancer research, Janus kinase 2 and Immune system. His Pharmacology research is multidisciplinary, incorporating perspectives in Cancer cell, Paclitaxel, Paclitaxel Poliglumex and Erlotinib. In his study, which falls under the umbrella issue of Pixantrone, International Prognostic Index, Ifosfamide and Progressive disease is strongly linked to Aggressive Non-Hodgkin Lymphoma.

Between 2009 and 2020, his most popular works were:

  • Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial (91 citations)
  • Pixantrone dimaleate versus other chemotherapeutic agents as a single-agent salvage treatment in patients with relapsed or refractory aggressive non-Hodgkin lymphoma: a phase 3, multicentre, open-label, randomised trial. (81 citations)
  • Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial (78 citations)

In his most recent research, the most cited papers focused on:

  • Internal medicine
  • Cancer
  • Gene

His primary areas of study are Internal medicine, Pacritinib, Surgery, Pixantrone and Myelofibrosis. His work in Internal medicine is not limited to one particular discipline; it also encompasses Gastroenterology. His studies examine the connections between Gastroenterology and genetics, as well as such issues in Diffuse large B-cell lymphoma, with regards to Pharmacology.

His Pacritinib study incorporates themes from Cancer research and Janus kinase 2. Jack W. Singer has researched Surgery in several fields, including Rituximab, Lymphoma and Oncology. His research on Myelofibrosis also deals with topics like

  • Randomized controlled trial together with Ruxolitinib,
  • Clinical endpoint together with Nausea and Cytopenia,
  • Adverse effect, which have a strong connection to Neutropenia.

Best Publications

  • Mechanisms of action of arsenic trioxide.

    Wilson H. Miller;Hyman M. Schipper;Janet S. Lee;Jack Singer

  • One hundred patients with acute leukemia treated by chemotherapy, total body irradiation, and allogeneic marrow transplantation.

    ED Thomas;CD Buckner;M Banaji;RA Clift

  • Marrow transplantation for acute nonlymphoblastic leukemia in first remission.

    Thomas Ed;Buckner Cd;Clift Ra;Fefer A

  • Marrow Transplantation for the Treatment of Chronic Myelogenous Leukemia

    E D Thomas;R A Clift;A Fefer;F R Appelbaum

  • Precursors of colony-forming cells in humans can be distinguished from colony-forming cells by expression of the CD33 and CD34 antigens and light scatter properties.

    R G Andrews;J W Singer;I D Bernstein

  • Recombinant Granulocyte-Macrophage Colony-Stimulating Factor after Autologous Bone Marrow Transplantation for Lymphoid Cancer

    John Nemunaitis;John Nemunaitis;John Nemunaitis;Susan N. Rabinowe;Jack W. Singer;Jack W. Singer;Jack W. Singer;Philip J. Bierman

  • Monoclonal antibody 12-8 recognizes a 115-kd molecule present on both unipotent and multipotent hematopoietic colony-forming cells and their precursors

    Robert G. Andrews;Jack W. Singer;Irwin D. Bernstein

  • Graft-versus-host disease and survival in patients with aplastic anemia treated by marrow grafts from HLA-identical siblings. Beneficial effect of a protective environment.

    R Storb;R L Prentice;C D Buckner;R A Clift

  • Autologous transplantation with peripheral blood mononuclear cells collected after administration of recombinant granulocyte stimulating factor

    W Bensinger;J Singer;F Appelbaum;K Lilleby

  • Graft-versus-Host Disease as Adoptive Immunotherapy in Patients with Advanced Hematologic Neoplasms

    K M Sullivan;R Storb;C D Buckner;A Fefer

  • Clonal development, stem-cell differentiation, and clinical remissions in acute nonlymphocytic leukemia

    Philip J. Fialkow;Jack W. Singer;Wendy H. Raskind;John W. Adamson

  • Evidence for a Multistep Pathogenesis of a Myelodysplastic Syndrome

    Wendy H. Raskind;Wendy H. Raskind;Nagendra Tirumali;Nagendra Tirumali;Robert Jacobson;Robert Jacobson;Jack Singer;Jack Singer

  • Cell lines and clinical isolates derived from Ph1-positive chronic myelogenous leukemia patients express c-abl proteins with a common structural alteration

    James B. Konopka;Susan M. Watanabe;Jack W. Singer;Steven J. Collins

  • Acute nonlymphocytic leukemia: heterogeneity of stem cell origin.

    Philip J. Fialkow;Jack W. Singer;John W. Adamson;Kalpana Vaidya

  • Use of recombinant human granulocyte-macrophage colony-stimulating factor in autologous marrow transplantation for lymphoid malignancies.

    J Nemunaitis;JW Singer;CD Buckner;R Hill

  • Marrow Transplantation in Thirty Untransfused Patients with Severe Aplastic Anemia

    Storb R;Thomas Ed;Buckner Cd;Clift Ra

  • Pacritinib vs Best Available Therapy, Including Ruxolitinib, in Patients With Myelofibrosis: A Randomized Clinical Trial

    John Mascarenhas;Ronald Hoffman;Moshe Talpaz;Aaron T. Gerds

  • Paclitaxel poliglumex (XYOTAX, CT-2103): a macromolecular taxane.

    Jack W. Singer

  • Pacritinib versus best available therapy for the treatment of myelofibrosis irrespective of baseline cytopenias (PERSIST-1): an international, randomised, phase 3 trial

    Ruben A. Mesa;Alessandro M. Vannucchi;Adam Mead;Miklos Egyed

  • Phase III trial comparing paclitaxel poliglumex (CT-2103, PPX) in combination with carboplatin versus standard paclitaxel and carboplatin in the treatment of PS 2 patients with chemotherapy-naïve advanced non-small cell lung cancer.

    Corey J. Langer;Kenneth J. O’Byrne;Mark A. Socinski;Sergei M. Mikhailov

Frequent Co-Authors

E. Donnall Thomas
E. Donnall Thomas University of Washington
Jean E. Sanders
Jean E. Sanders Fred Hutchinson Cancer Research Center
John W. Adamson
John W. Adamson University of California, San Diego
Frederick R. Appelbaum
Frederick R. Appelbaum Fred Hutchinson Cancer Research Center
Kristine Doney
Kristine Doney Fred Hutchinson Cancer Research Center
Rainer Storb
Rainer Storb Fred Hutchinson Cancer Research Center
John Nemunaitis
John Nemunaitis Gradalis (United States)
Wendy H. Raskind
Wendy H. Raskind University of Washington
Buckner Cd
Buckner Cd National Cancer Institute
William I. Bensinger
William I. Bensinger Fred Hutchinson Cancer Research Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Exploring a career in healthcare doesn’t always mean becoming a doctor. There are flexible, rewarding options in nursing, administration, and beyond. Many students opt for direct entry msn programs online, which allow non-nurses to swiftly transition into advanced nursing roles, often through accelerated online study.

If you’re looking for more accessible entry points, several direct admit nursing programs offer streamlined admissions for first-time students, with some schools removing exam barriers. This is reinforced by the rising number of accredited programs where do all nursing schools require the teas is a common question—fortunately, many do not, offering more accessible pathways.

Medical administration roles are also in demand. Pursuing certification through one of the medical billing and coding financial aid programs can lead to stable careers, especially for those seeking flexible or remote work. All these pathways provide vital support to the healthcare system, while also offering strong job opportunities for students who may want alternatives to traditional medical school.

Best Scientists Citing Jack W. Singer

Trending Scientists

Recently Published Articles